Citation Impact
Citing Papers
Assembly of a Functional HCV Glycoprotein Heterodimer
2007
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Current progress in development of hepatitis C virus vaccines
2013
Extrahepatic Manifestations of Hepatitis C Infection
2003
The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection
1997
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Liver fibrosis
2005 Standout
Small-Vessel Vasculitis
1997 Standout
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies
1995
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Circulating transforming growth factor beta 1 (TGF-beta 1) in Guillain-Barre syndrome: decreased concentrations in the early course and increase with motor function
1998
Paraproteinemic Neuropathies
2001
Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies
1996
Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis
2002
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure
2013 StandoutNobel
Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
2013
Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C
2006
Guillain-Barré syndrome
2016 Standout
Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus
2009
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
Hepatitis C virus comes full circle
2005
Hepatitis C virus entry: Molecular biology and clinical implications
2006
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature
2011
Cell entry of hepatitis C virus
2006
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Hepatitis C virus–induced cryoglobulinemia
2009
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems
2008
High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI
2006
Detection of Type 2–Like T–Helper Cells in Hepatitis C Virus Infection: Implications for Hepatitis C Virus Chronicity
1997
Adaptive Immunity to the Hepatitis C Virus
2010
Immune Thrombocytopenic Purpura
2002 Standout
The Antiphospholipid Syndrome
2002 Standout
Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
1990
HCV and HGV in B-cell non-Hodgkin's lymphoma
1998
Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses
2014
Natural history of HCV infection
2000
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
2006 StandoutNobel
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Hepatitis C Virus Entry
2007 StandoutNobel
Hepatitis C virus (HCV) infection and cryoglobulinemia: Analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology
2000
Hepatitis C Virus: 30 Years after Its Discovery
2019 StandoutNobel
Expansion of peripheral blood CD5+ B cells is associated with mild disease in chronic hepatitis C virus infection
2000
Hepatitis C Virus Glycoproteins Mediate Low pH-dependent Membrane Fusion with Liposomes
2005
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation
1998 Standout
Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?
2015
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
Hepatitis C: Natural History of a Unique Infection
1995
Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate
2012
Paraneoplastic syndromes of the spinal cord, nerve, and muscle
2000
MIXED CRYOGLOBULINEMIA SECONDARY TO HEPATITIS C VIRUS INFECTION
1996
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design
2015
Replication of hepatitis C virus
2007 StandoutNobel
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies
2008
Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study
2001
Cooperativity in Virus Neutralization by Human Monoclonal Antibodies to Two Adjacent Regions Located at the Amino Terminus of Hepatitis C Virus E2 Glycoprotein
2012
Will There Be a Vaccine to Prevent HCV Infection?
2014
Heparin-Associated Thrombocytopenia: The Antibody Is Not Heparin Specific
1992
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques
2011
Immunology and Clinical Importance of Antiphospholipid Antibodies
1991
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies
2005
High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry
2006
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
2007
Course and outcome of hepatitis C
2002
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation
2010
Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein
2008
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4
1994
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
2008 Standout
Selective IgG subclass deficiency: quantification and clinical relevance
1990
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
2005 StandoutScience
Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates
2017
Immunizations with Chimeric Hepatitis B Virus-Like Particles to Induce Potential Anti-Hepatitis C Virus Neutralizing Antibodies
2007
Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis.
1990 StandoutNobel
Increased Frequency of Surface IgA-Positive Plasma Cells in the Intestinal Lamina Propria and Decreased IgA Excretion in Hyper IgA (HIGA) Mice, a Murine Model of IgA Nephropathy with Hyperserum IgA
2000 StandoutNobel
COAGULATION DISORDERS IN CANCER
1996
Neutralizing Antibody Response to Hepatitis C Virus
2011
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies
2010
Antinuclear Autoantibodies Specific for Lamins
1988
Guillain–Barré syndrome, CIDP and other chronic immune‐mediated neuropathies
1998
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Circulating IgA, IgG, and IgM class antibody against Haemophilus parainfluenzae antigens in patients with IgA nephropathy
1996
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Works of L Intrator being referenced
Antiphospholipid antibodies in adults with immune thrombocytopenic purpura
2008
Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome
1997
Low Molecular Weight Heparin Fractions as an Alternative Therapy in Heparin-induced Thrombocytopenia
1987
Immunological disorders in C virus chronic active hepatitis: A prospective case-control study
1994
Spontaneous recurrent fetal wastage and autoimmune abnormalities: A study of fourteen cases
1986
Serum IgG subclasses in secondary immunodeficiencies.
1988
An Increase in Circulating IgA Antibodies to Gliadin in IgA Mesangial Glomerulonephritis
1987
Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome
1996
Early weight loss and high serum tumor necrosis factor‐α levels in polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome
1994
Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection
2005
Thrombocytopenia Related to Synthetic Heparin Analogue Therapy
1985
[Circulating anticoagulant of the antiprothrombinase type. Retrospective study of 134 cases].
1987